Cannabis Abstinence During Treatment and One-Year Follow-Up: Relationship to Neural Activity in Men

Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology (Impact Factor: 7.05). 04/2014; 39(10). DOI: 10.1038/npp.2014.82
Source: PubMed


Cannabis is among the most frequently-abused substances in the United States. Cognitive control is a contributory factor in the maintenance of substance use disorders and may relate to treatment response. Therefore, we assessed whether cognitive-control-related neural activity prior to treatment differs between treatment-seeking cannabis-dependent and healthy individuals and relates to cannabis-abstinence measures during treatment and one-year follow-up. Cannabis-dependent males (N=20) completed a functional magnetic resonance imaging (fMRI) cognitive-control (Stroop) task prior to a 12-week randomized controlled trial of cognitive behavioral therapy and/or contingency management. A healthy-comparison group (N=20) also completed the fMRI task. Cannabis-use was assessed by urine toxicology and self-report during treatment, and by self-report across a 1-year follow-up period (N=18). The cannabis-dependent group displayed diminished Stroop-related neural activity relative to the healthy-comparison group in multiple regions including those strongly implicated in cognitive control and addiction-related processes (e.g. dorsolateral prefrontal cortex and ventral striatum). The groups did not significantly differ in response times (cannabis-dependent N=12; healthy-comparison N=14). Within the cannabis-dependent group, greater Stroop-related activity in regions including the dorsal anterior cingulate cortex was associated with less cannabis use during treatment. Greater activity in regions including the ventral striatum was associated with less cannabis use during one-year post-treatment follow-up. These data suggest that lower cognitive-control-related neural activity in classic "control" regions (e.g., dorsolateral prefrontal cortex, dorsal anterior cingulate) and classic "salience/reward/learning" regions (e.g., ventral striatum) differentiates cannabis-dependent from healthy individuals and relates to less abstinence within-treatment and during long-term follow-up. Clinically, results suggest that treatment development efforts that focus on enhancing cognitive control in addition to abstinence may improve treatment outcomes in cannabis dependence.Neuropsychopharmacology accepted article peview online, 07 April 2014; doi:10.1038/npp.2014.82.

Download full-text


Available from: Kathleen Carroll, Nov 13, 2015
  • Source
    • "The relationship between cognitive control and cannabis use is thought to be bidirectional: Chronic cannabis use may impair cognitive control, but relative poor levels of cognitive control may also predispose individuals to CUDs (Cousijn et al., 2013b, 2014a; Crean et al., 2011). A recent study in adult treatment seeking cannabis users compared to healthy matched controls showed that lower brain activations during the Stroop task in brain areas involved in the regulation of behaviour (anterior cingulate cortex) and reward processing (ventral striatum) predicted more cannabis use one year later (Kober et al., 2014). Moreover, functioning of the brain network involved in cognitive control during a working memory task predicted cannabis use six months later in non-treatment seeking adult heavy cannabis users (Cousijn et al., 2014a,b). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cannabis use disorders (CUDs) are the most prevalent substance use disorders among adolescents in treatment. Yet, little is known about the neuropsychological mechanisms underlying adolescent CUDs. Studies in adult cannabis users suggest a significant role for cognitive control and cannabis-oriented motivational processes, such as attentional bias, approach bias, and craving in CUDs. The current 6-month prospective study investigated the relationships between attentional bias, approach bias, craving, cognitive control, and cannabis use in adolescent patients in treatment for a primary or secondary CUD. Moreover, we investigated if these motivational processes and cognitive control could predict treatment progression after 6 months. Adolescents with a CUD had an attentional but no approach bias towards cannabis. In contrast to adult findings on the role of attentional bias, approach bias and cognitive control, only cannabis craving significantly correlated with current cannabis use and predicted cannabis use-related problems and abstinence from cannabis 6 months later. These findings identify craving as a predictor of treatment outcome, thereby supporting an important role for craving in the course of adolescent cannabis use and dependence. This prospective study is among the first to investigate neuropsychological mechanisms underlying adolescent CUDs, warranting future longitudinal studies. Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.
    Full-text · Article · Apr 2015 · Developmental Cognitive Neuroscience
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This preliminary study examined the extent to which regional brain activation during a reward cue antisaccade (AS) task was associated with 6-month treatment outcome in adolescent substance users. Antisaccade performance provides a sensitive measure of executive function and cognitive control, and generally improves with reward cues. We hypothesized that when preparing to execute an AS, greater activation in regions associated with cognitive and oculomotor control supporting AS, particularly during reward cue trials, would be associated with lower substance use severity at 6-month follow-up. Adolescents (n=14, ages 14-18) recruited from community-based outpatient treatment completed an fMRI reward cue AS task (reward and neutral conditions), and provided follow-up data. Results indicated that AS errors decreased in reward, compared to neutral, trials. AS behavioral performance, however, was not associated with treatment outcome. As hypothesized, activation in regions of interest (ROIs) associated with cognitive (e.g., ventrolateral prefrontal cortex) and oculomotor control (e.g., supplementary eye field) during reward trials were inversely correlated with marijuana problem severity at 6-months. ROI activation during neutral trials was not associated with outcomes. Results support the role of motivational (reward cue) factors to enhance cognitive control processes, and suggest a potential brain-based correlate of youth treatment outcome. Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.
    Full-text · Article · May 2015 · Developmental Cognitive Neuroscience
  • [Show abstract] [Hide abstract]
    ABSTRACT: Despite studies showing the relevance of different decision-making abilities, including response inhibition, to likelihood of using substances during adolescence, few have examined these neural processes among high-risk, substance-using youth. The current study explored associations between alcohol and marijuana use and functional activation differences during Stroop performance among a large sample (N=80) of ethnically-diverse, high-risk youth in an fMRI-based task. In the absence of associations between substance use and task behavioral performance, adolescents with greater alcohol use showed less activation during the more cognitively difficult portion of the task across clusters in bilateral cuneus and precuneus, and right and left superior temporal gyrus. No associations were observed with marijuana use. The current results may suggest neural patterns of deactivation in regions important for cognitive control, such that alcohol use may confer additional risk for future decreased inhibition among these high-risk adolescents. The ability to inhibit prepotent responses has been shown to predict later response to treatment, and early interventions to encourage further development of cognitive control could represent promising options for treatment.
    No preview · Article · Sep 2015
Show more